Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TATA Health International Holdings Ltd. ( (HK:1255) ) has shared an update.
TATA Health International Holdings Limited has announced further delays in the publication of its 2024 Interim Results, 2024 Annual Results, and 2025 Interim Results, as well as the dispatch of the corresponding reports. The company is finalizing the contents of these financial documents, with new publication dates set for late September 2025. Additionally, trading in the company’s shares remains suspended since April 2024, pending the fulfillment of resumption guidance. The board has scheduled meetings in late September to consider and approve the delayed results and potential dividends.
More about TATA Health International Holdings Ltd.
Technical Sentiment Signal: Sell
Current Market Cap: HK$72.85M
See more insights into 1255 stock on TipRanks’ Stock Analysis page.